September 18, 2014 / 6:27 AM / 3 years ago

BRIEF-Sinclair IS Pharma FY rev up 15 pct

Sept 18 (Reuters) - Sinclair IS Pharma Plc :

* Revenue increased by 15% to £63.6m (2013: £55.4m)

* Adjusted ebitda 2 growth of 39% to £10.0m (2013: £7.2m)

* Loss per share falls to 1.2p(2013: 4.1p)

* Net debt at year end of £40.2 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below